Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI) commonly indicated for the treatment of obsessive-compulsive disorder, depression, panic disorder, and social anxiety. This category comprises… Read more











![Chemical structure of 4-Oxo-10-[4-(trifluoromethyl)phenyl]-8,15-dioxa-5,9-diazahexadeca-2,9-dienoic acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1076198-14-5-4-Oxo-10-4-trifluoromethylphenyl-815-dioxa-59-diazahexadeca-29-dienoic-acid.png&w=3840&q=75)


























![Chemical structure of N-[4-(Trifluoromethyl)benzoyl]glycine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F89035-91-6-N-4-Trifluoromethylbenzoylglycine.png&w=3840&q=75)




Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI) commonly indicated for the treatment of obsessive-compulsive disorder, depression, panic disorder, and social anxiety. This category comprises high-quality reference standards, pharmacopeial and non-pharmacopeial impurities, and stable isotope labelled compounds essential for rigorous pharmaceutical analysis. Laboratory professionals utilize these materials for critical tasks including impurity profiling, analytical method validation, and the routine quality control of the active pharmaceutical ingredient. Stable isotope labelled fluvoxamine compounds are frequently employed as internal standards in mass spectrometry to enhance the accuracy and reproducibility of quantitative bioanalytical assays. Furthermore, the availability of well-characterized degradation products and related substances supports comprehensive stability studies and helps ensure compliance with international regulatory guidelines. By providing reliable reference materials, this collection assists researchers in developing sensitive analytical methods and maintaining the safety, potency, and consistent quality of drug products throughout the development and manufacturing lifecycle.